Last reviewed · How we verify

NCT05888246

Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram

Completed NA Last updated 28 July 2023
What this trial tests

NA trial testing Magnetocardiogram in Healthy People in 412 participants. Completed in 14 May 2022.

Timeline
7 May 2022
Primary endpoint
14 May 2022
14 May 2022

Quick facts

Lead sponsorHangzhou Nuochi Life Science Co., Ltd.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment412
Start date7 May 2022
Primary completion14 May 2022
Estimated completion14 May 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Hangzhou Nuochi Life Science Co., Ltd.

Who can join

Adults 18 to 70, any sex, with Healthy People. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective and observational clinical study of measuring the range of cardiac magnetic parameters in healthy people with the magnetocardiogram manufactured by Hangzhou Nuochi Life Science Co., LTD

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Magnetocardiogram

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05888246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing